Clinical Trials Directory

Trials / Completed

CompletedNCT01209845

Ketamine for Low Mood States in the ER

Low Dose Ketamine for Low Mood States: An Emergency Department Feasibility Study for Depressed Patients

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
14 (actual)
Sponsor
Yale University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The investigators hope to see if a commonly used drug such as ketamine could help depressed ER patients feel better and improve their mood quickly.

Detailed description

Rapid-onset antidepressants could have important clinical impact if their benefits extended to Emergency Department (ED) patients. We hope to explore the preliminary feasibility, tolerability and efficacy of single-dose, intravenous (IV) ketamine in depressed ED patients who presented with suicide ideation (SI). The manuscript (article) for this study has been retracted because Yale University conducted an investigation that determined that the description of the research was not accurate. The article misrepresents both the protocol-specified doses and the actual delivered doses of ketamine.

Conditions

Interventions

TypeNameDescription
DRUGketamineintravenous ketamine(0.2 mg/kg) over 1-2 minutes IV

Timeline

Start date
2010-04-01
Primary completion
2010-12-01
Completion
2010-12-01
First posted
2010-09-27
Last updated
2020-08-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01209845. Inclusion in this directory is not an endorsement.